Editorial: Diabetic hearts and biguanides-a counter-reply. 1976

P Biron

UI MeSH Term Description Entries
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001645 Biguanides Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. Biguanide

Related Publications

P Biron
September 1976, Canadian Medical Association journal,
P Biron
January 2015, Anais brasileiros de dermatologia,
P Biron
February 1977, Die Medizinische Welt,
P Biron
January 1997, Bulletin of the World Health Organization,
P Biron
August 1999, Journal of clinical anesthesia,
P Biron
December 1976, Genetical research,
P Biron
May 1975, British medical journal,
P Biron
June 1989, British journal of hospital medicine,
P Biron
March 1976, British medical journal,
Copied contents to your clipboard!